Advanced search
Publication Cover
Modern Rheumatology Case Reports Volume 5, 2021 - Issue 1
Journal homepage
168
Views
2
CrossRef citations to date
0
Altmetric
Case Reports

Combination immunosuppressant therapy for rapidly progressive pyoderma gangrenosum in a child

Shinji Kawabea Department of Infection and Immunology, Aichi Children’s Health and Medical Center, Obu, Aichi, Japan
,
Naomi Iwataa Department of Infection and Immunology, Aichi Children’s Health and Medical Center, Obu, Aichi, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6149-1358
ORCID Icon,
Emi Nishidab Department of Dermatology, Aichi Children’s Health and Medical Center, Obu, Aichi, Japan;c Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan
,
Toaki Kohaguraa Department of Infection and Immunology, Aichi Children’s Health and Medical Center, Obu, Aichi, Japan
,
Naoki Abea Department of Infection and Immunology, Aichi Children’s Health and Medical Center, Obu, Aichi, Japan
,
Haruna Nakasekoa Department of Infection and Immunology, Aichi Children’s Health and Medical Center, Obu, Aichi, Japan
&
Akimichi Moritac Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, JapanORCID Iconhttps://orcid.org/0000-0001-8372-3754
ORCID Icon show all
Pages 137-140 | Received 06 Nov 2019, Accepted 24 Mar 2020, Published online: 05 Oct 2020

References

  • Anstead GM. Steroids, retinoids, and wound healing. Adv Wound Care. 1998;11:277–285.
  • Kechichian E, Haber R, Mourad R, et al. Pediatric pyoderma gangrenosum: a systematic review and update. Int J Dermatol. 2017;56:486–495.
  • Partridge ACR, Bai JW, Rosen CF, et al. Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials. Br J Dermatol. 2018;179:290–295.
  • Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol. 2012;13:191–211.
  • Chow RK, Ho VC. Treatment of pyoderma gangrenosum. J Am Acad Dermatol. 1996;34:1047–1060.
  • Ormerod AD, Thomas KS, Craig FE, et al.; on behalf of the UK Dermatology Clinical Trials Network’s STOP GAP team. Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. BMJ. 2015;350:h2958.
  • Brooklyn TN, Dunnill MG, Shetty A, et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut. 2006;55:505–509.
  • Cafardi J, Sami N. Intravenous immunoglobulin as salvage therapy in refractory pyoderma gangrenosum: report of a case and review of the literature. Case Rep Dermatol. 2014;6:239–244.
  • Herberger K, Dissemond J, Brüggestrat S, et al. Biologics and immunoglobulins in the treatment of pyoderma gangrenosum – analysis of 52 patients. J Dtsch Dermatol Ges. 2019;17:32–41.
  • Hasselmann DO, Bens G, Tilgen W, et al. Pyoderma gangrenosum: clinical presentation and outcome in 18 cases and review of the literature. J Dtsch Dermatol Ges. 2007;5:560–564.
  • von den Driesch P. Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol. 1997;137:1000–1005.
  • Lahiri M, Dixon WG. Risk of infection with biologic antirheumatic therapies in patients with rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2015;29:290–305.
  • Bennett ML, Jackson JM, Jorizzo JL, et al. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore). 2000;79:37–46.
  • Goodarzi H, Sivamani RK, Garcia MS, et al. Effective strategies for the management of pyoderma gangrenosum. Adv Wound Care (New Rochelle). 2012;1:194–199.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.